Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes

Primary membranous nephropathy is usually caused by antibodies against the podocyte antigen membrane M-type phospholipase A2 receptor (PLA2R). The treatment of membranous nephropathy is not fully satisfactory. The calcineurin inhibitor tacrolimus is used to treat membranous nephropathy, but recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuarental, Leticia, Valiño-Rivas, Lara, Mendonça, Luis, Saleem, Moin, Mezzano, Sergio, Sanz, Ana Belen, Ortiz, Alberto, Sanchez-Niño, Maria Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408934/
https://www.ncbi.nlm.nih.gov/pubmed/32664235
http://dx.doi.org/10.3390/jcm9072178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408934/
https://www.ncbi.nlm.nih.gov/pubmed/32664235
http://dx.doi.org/10.3390/jcm9072178

Ejemplares similares